In the fast-paced, high-stakes world of pharmaceutical and life sciences, the demand for specialized, compliant, and advanced facilities has never been greater. As the pharmaceutical sector continues to evolve with cutting-edge research, new treatments, and complex production needs, there is a growing need for infrastructure that can meet rigorous regulatory standards while supporting innovation. Mavcor, a leader in the construction of facilities for this vital sector, has established itself as a key player by offering a blend of technical expertise, innovation, and collaboration to deliver high-quality, custom-built spaces. Founded with a vision to turn complex projects into reality, Mavcor has earned a reputation for creating precise and flexible facilities for pharmaceutical and life sciences companies. From initial design to full-scale construction, it is the go-to partner for organizations looking to develop facilities that meet the stringent requirements of research, development, and production. Nicholas Mucci, president of Mavcor, emphasizes the company’s approach: “We look at the big picture. We structure teams, coordinate supply chains, and guide all professionals toward a shared goal of delivering advanced facilities that meet both business objectives and regulatory standards.” This holistic view of project delivery ensures that every aspect of a facility’s design, construction, and functionality is aligned with the client’s overarching business and operational goals.
Clinical Trial
Gene Therapy Clearly Communicated: The Importance of Patient-Centricity, Anan Omnichannel Approach, and Health Literacy
Tara Moroz, PhD, Sr. Director, Global Medical Communications and Content, Specialty Care, Rare Disease, Pfizer, Inc (NYSE: PFE)
Life Science Consulting
What About Rare Diseases - Canada's National Strategy to Support Innovation and Access
France Lebel, Senior Director Medical Affairs, Recordati [BIT: REC]
Life Sciences Marketing and Communication
The Expanding Role of Nano-Emulsions in the Cannabis Edibles Market
Ivan A Salazar, Plant Production Manager at Organigram
Clinical Laboratory
A Synopsis Of Clinical Engineering/ Biomedical Engineering
Dr. Haniff Murray, PhD, Clinical Engineer/Alternate Manager at Memorial Healthcare System
Life Science Analytics
Why Your Hospital Can't Wait to Reinvent Their Construction Practices
Karin Henderson, Executive Director of Strategic Facilities Delivery, Cone Health
Life Science Analytics
Driving Factors and Innovations in Healthcare Real Estate Services for Value-Based and Patient-Centered Care
Mark Yerrick, System Vice President, Facilities and Real Estate, Care New England
Life Science Analytics
Hospital-Owned Business and Ambulatory Occupancies: Vacant Square Footage, Consolidations, and the Real Estate Cycle in a Post COVID Market
Dan Keller, System Director of Facilities & Engineering, Tower Health
IN MY OPINION
Life Science Analytics
Healthcare Facilities' Aging Infrastructure: Problem or Opportunity?
Michael C. Walker, EdD, Director Real Estate Operations, Texas Health Resources
LAST WORD
Life Science Analytics
Inappropriate Antibiotic Prescribing in Long-Term Care Facilities: A Growing Concern
Shantel Rodriguez, RN, BSN, Chief Nursing Officer, MB Healthcare
IN FOCUS
Environmental Life Sciences Shaping Canada's Biodiversity Strategy
Canada protects its diverse ecosystems through conservation networks, nature-based climate solutions, strong legislation, and interdisciplinary research to address biodiversity loss and the impacts of climate change.
Canada's Sustainable Future in Life Science Construction
Canada’s life sciences construction sector is pioneering net-zero labs by integrating stringent carbon standards, advanced HVAC systems, sustainable materials, and digital tools—balancing high energy demands.
EDITORIAL
The Infrastructure Powering Canada’s Scientific Advancement
Life science construction firms are integrators of scientific precision, regulatory expertise and future-ready engineering. It enables organizations to operate in environments where even the smallest variable can influence outcomes. From cleanrooms and GMP suites to complex laboratory systems and controlled research spaces, they design infrastructure that allows science to function at its highest standard. They contribute by translating scientific needs into physical environments that ensure safety and compliance without compromising flexibility for future growth.
As demand grows, the complexity of facility requirements rises. Canadian construction specialists are meeting these challenges with adaptive design models, contamination-control strategies and a deep understanding of national and global regulations. They help organizations navigate the intricate intersection of infrastructure and compliance, ensuring that facilities support not only current scientific ambitions but also the rapid advancements coming in the future.
In this edition of the Life Sciences Review Canada, we examine the recent developments in life science construction services and the pivotal role these firms play in building the environments that support Canada’s expanding research and innovation landscape.
We have also curated thought leadership articles from industry experts, including France Lebel, Senior Director Medical Affairs at Recordati and Shantel Rodriguez, BSN, RN, RAC-CT, LTC-CIP, Chief Nursing Officer at MB Healthcare.
The publication spotlights Mavcor as the cover feature, recognizing its expertise in constructing precision-engineered facilities for the pharmaceutical and life sciences industries with a focus on collaboration, innovative technology and regulatory compliance.
We hope this edition of the Life Sciences Review Canada helps you find the right partner for your business requirements.
